Inhibikase Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $65k | 50k | 1.30 |
| 2024-06-30 | $49k | 37k | 1.31 |
| 2024-03-31 | $62k | 29k | 2.16 |
| 2023-09-30 | $41k | 29k | 1.41 |
| 2023-06-30 | $52k | 15k | 3.48 |